Addressing critical issues and emerging TheRapEutics in TrAnsplanTation for COVID-19 (TREAT-COVID)

Study Lead

Manuel Escoto

University of Alberta

Overview

Despite being vaccinated, transplant recipients remain at high risk for severe COVID-19 outcomes. However, they are often excluded from studies due to design challenges, resulting in limited data. Their families and caregivers also face increased stress, mental health challenges, and financial burdens.

The TREAT-COVID study aims to address these barriers by understanding how COVID-19 continues to affect child and/or adult transplant recipients and their families or caregivers living in Canada. This is in hopes of creating a flexible national plan to inform better policies and improve patient health.

As a study participant, you will be asked to complete online questionnaires every three months for up to two years. As a transplant recipient, if you get COVID-19, you and your family member will be asked to complete additional questions on receiving treatments, your mental health and wellness, and your financial situation.

For more information about this study, please visit: https://cdtrp.ca/en/treatcovid/

This study was approved by the University of Alberta Research Ethics Board (lead institution): Pro00131530

Eligibility

– Be an organ or stem cell transplant recipient, or
– Be a caregiver of an organ or stem cell transplant recipient*, or
– Be followed by one of the participating transplant centres.

*Please note that for a family member/caregiver wanting to enrol, the transplant recipient they care for must be enrolled in the study first.

Participating in this study will provide useful information about COVID-19 treatments and issues to policymakers, clinicians, and patients and their families.

This study is currently open to participants in British Columbia, Northern Alberta, Ontario, and Quebec. Please enrol through the link associated with your region:
British Columbia and Yukon: https://bit.ly/3WRUrqD
Northern Alberta: https://bit.ly/40Ix8Rj
Ontario: https://bit.ly/4kfqTMW
Quebec: https://bit.ly/4j9YGGA
All other regions: https://bit.ly/3EA8n26   

Type of Participation

Interview, Survey

Location

Alberta, British Columbia, Ontario, Quebec

Related studies

  • Kidney Transplant Stakeholders’ Perspectives on the Future of Xenotransplantation in Canada

    Overview:

    Study type: Focus Group, Interview

    January 7, 2026

  • A qualitative study exploring patient and caregiver perspectives and experiences on disaster management in kidney care

    Overview:

    Study type: Interview

    January 7, 2026

  • Equitable Pandemic Communication Strategies to Support Sexual and Gender Minority Transplant Patients

    Overview:

    Study type: Interview

    December 4, 2025